Range Nuclear Renaissance ETF vs Philip Morris International Inc. — how do they compare? Range Nuclear Renaissance ETF trades at $66.18, while Philip Morris International Inc. trades at $186.66 (market cap $287.92B). The key difference: Philip Morris International Inc. pays a 3.18% dividend while Range Nuclear Renaissance ETF pays none, and Philip Morris International Inc. is trading nearer its 52-week high, Range Nuclear Renaissance ETF nearer its low. Which is the better fit depends on your goals.
| NUKZ | PM | |
|---|---|---|
Sector | Sector/Thematic | Consumer Staples |
52-Week High | $76.23 | $200.17 |
52-Week Low | $59.84 | $144.33 |
Market Cap | — | $287.92B |
Enterprise Value | — | $331.04B |
Dividend Yield | — | 3.18% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Philip Morris International (PM) trades at $185.71, up 1.74% with a bearish technical signal. Recent earnings show beats in Q1 and Q2 2026, but the company cut its 2026 profit forecast due to a $500 million impairment and cost pressures. Fundamentals remain strong with a 25.56% net margin and $11.35B net income in 2025, though high debt and illicit market growth in Europe pose risks. Analyst consensus is bullish with a $211.17 price target.
The stock offers a solid dividend and brand strength via IQOS, but faces headwinds from currency swings, energy costs, and regulatory challenges. Upside depends on execution amid margin pressure, with the current price near the low end of analyst targets suggesting cautious optimism for long-term investors.
Trailing returns across standard periods
Range Nuclear Renaissance ETF seeks to track companies related to the nuclear energy industry. Its holdings may include businesses involved in uranium, nuclear power generation, reactors, and nuclear services.
Read more on NUKZ →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →